Differential expression of CCAAT/enhancer-binding protein-δ (C/EBPδ) in rat androgen-dependent tissues and human prostate cancer

Journal of Andrology

Volumn 22, Issue 3, 2001, Pages 471-480

  Yang, G ^a   Gregory, C W ^b   Shang, Q ^b   O'Brien, D A ^b   Zhang, Y L ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Testosterone; Transcription factor

Indexed keywords

ANDROGEN; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN DELTA; DIMETHYL SULFOXIDE; ETHYLENE GLYCOL DIMESYLATE; TESTOSTERONE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CASTRATION; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RAT; TESTOSTERONE BLOOD LEVEL;

ANDROGENS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; EPIDIDYMIS; HUMANS; MALE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TESTIS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035045253     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
2. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
3. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response
4. Regional expression of transforming growth factor-α in rat ventral prostate during postnatal development, after androgen ablation, and after androgen replacement
5. Regulation of androgen receptor mRNA and protein in the rat testis by testosterone
6. Prostate cancer schemes for androgen escape
7. Interleukin-6-specific activation of the C/EBPδ gene in hepatocytes is mediated by Stat3 and Sp1
8. Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity
9. CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy
10. One-hour downward capillary blotting of RNA at neutral pH
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
12. Cloning of the novel human myeloid-cell-specific C/EBPε transcription factor
13. The role of C/EBP genes in adipocyte differentiation
14. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
15. Transcriptional regulation of the platelet-derived growth factor α receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells
16. Expression of bcl-2 and the progression of human and rodent prostatic cancers
17. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction
18. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
19. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft
20. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences
21. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses
22. Isolation of a recombinant copy of the gene encoding C/EBP
23. Role of the CCAAT enhancer binding proteins (C/EBPs) in adiopocyte differentiation
24. Molecular biology of prostate carcinogenesis
25. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
26. Expression of transforming growth factor-β 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment
27. Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3′, 5′-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts
28. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors
29. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4, and 5
30. CCAAT/enhancer-binding protein δ regulates mammary epithelial cell G0 growth arrest and apoptosis
31. Cancer statistics, 1997
32. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP
33. Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement
34. The influence of aging on androgen dynamics in the male rat
35. Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium
36. Ig/EBP-1: A ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP
37. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription
38. Aging in the rat prostate. Reduction in detectable ventral prostate androgen receptor content
39. Testosterone metabolism by the prostate of the aging AXC rat
40. ATF-2 and C/EBPα can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation
41. Insulin-like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride-treated rats
42. Sertoli cell-spermatogenic cell interaction: The insulin-like growth factor-II/cation-independent mannose 6-phosphate receptor mediates changes in spermatogenic cell gene expression in mice
43. CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins
44. CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma
45. Apoptosis and related genes in the rat ventral prostate following androgen ablation in response to ethane dimethanesulfonate
46. CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis
47. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
48. Mutant and wild-type androgen receptors exhibit crosstalk on androgen-, glucocorticoid-, and progesterone-mediated transcription
49. Tissue-specific differences in the binding of nuclear proteins to a CCAAT motif in the promoter of the androgen-regulated C3 gene